A current perspective for patients with diabetes, hypertension, and hyperlipidemia

Medicare Advantage (MA) and Part D insurers are citing significant financial headwinds in earnings calls and the press. Statutory financial statements provide insights into emerging trends through year-end 2024.

This article highlights the key changes to premiums and plan offerings in the prescription drug plan (PDP) market.

Emerging trends in pharmacy shopping and related overdoses

This white paper focuses on one approach for improving drug utilization management: precision medicine through a method known as uplift modeling.

Biosimilars recently have made significant strides toward greater acceptance and utilization since their first U.S. approval in 2015, although challenges persist.